SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: McNabb Brothers who wrote (5687)9/24/1998 2:52:00 PM
From: Linda Kaplan  Read Replies (1) of 7041
 
Hank: I should think there's naturally a blip upward expected on the payment of $5 million, but after this I'd expect it to be downhill again. There shouldn't be news from the FDA for 10 months and there's a fair chance the FDA will disapprove the drug. If some of the longs are starting to say they expect lower Mexico sales, I figure they already know the sales in Mexico have lessened. I would expect after this that the stock will slowly erode in value. Then, if the drug is not approved by the FDA, it should really take a big fall. And if it is approved and sales are dismal, as they rightfully should be, since the drug purportedly doesn't work, it would go up after approval and then down and down and down. Either way, there shouldn't be much to keep the price up after this.

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News